The prognostic role of circulating tumor DNA across breast cancer molecular subtypes: A systematic review and meta-analysis
{{output}}
Objective: Circulating tumor DNA (ctDNA) is increasingly being used as a potential prognostic biomarker in cancer patients. We aimed to assess the prognostic value of ctDNA in different subtypes of breast cancer patients througho... ...
